Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results
Provided By GlobeNewswire
Last update: Mar 3, 2025
Total Revenue of $71.3 million for FY2024, growing 45% over FY2023;
Gross margins of 78% for FY2024, up 5% points over FY2023;
Read more at globenewswire.com0.713
-0.08 (-10.09%)
Find more stocks in the Stock Screener
BDSX Latest News and Analysis
15 hours ago - ChartmillGet insights into the top gainers and losers of Monday's after-hours session.The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
